| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
| Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
| Age | 1045 |
|
|
|
|
| ≤60 | 578 | Reference |
|
|
|
| >60 | 467 | 1.418 (0.913~2.201) | 0.120 |
|
|
| T stage | 1042 |
|
|
|
|
| T1 & T2 | 877 | Reference |
|
|
|
| T3 & T4 | 165 | 2.037 (1.252~3.314) | 0.004 | 0.749 (0.374~1.497) | 0.413 |
| N stage | 1027 |
|
|
|
|
| N0 | 504 | Reference |
|
|
|
| N1 & N2 & N3 | 523 | 3.584 (2.089~6.148) | <0.001 | 1.657 (0.836~3.285) | 0.148 |
| M stage | 891 |
|
|
|
|
| M0 | 872 | Reference |
|
|
|
| M1 | 19 | 7.697 (4.112~14.407) | <0.001 | 4.616 (2.130~10.005) | <0.001 |
| Pathologic stage | 1024 |
|
|
|
|
| Stage I & Stage II | 776 | Reference |
|
|
|
| Stage III & Stage IV | 248 | 3.870 (2.474~6.055) | <0.001 | 2.911 (1.398~6.064) | 0.004 |
| ER status | 996 |
|
|
|
|
| Negative | 230 | Reference |
|
|
|
| Positive | 766 | 0.523 (0.326~0.838) | 0.007 | 0.467 (0.200~1.091) | 0.078 |
| PR status | 993 |
|
|
|
|
| Negative | 331 | Reference |
|
|
|
| Positive | 662 | 0.529 (0.336~0.833) | 0.006 | 0.770 (0.341~1.738) | 0.529 |
| HER2 status | 695 |
|
|
|
|
| Negative | 541 | Reference |
|
|
|
| Positive | 154 | 1.481 (0.740~2.965) | 0.267 |
|
|
| GGCT | 1045 |
|
|
|
|
| Low | 521 | Reference |
|
|
|
| High | 524 | 2.039 (1.288~3.227) | 0.002 | 2.124 (1.217~3.706) | 0.008 |